|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 25 May 2006
doi: 10.1242/dev.02424
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A-crystallin expression prevents
-crystallin insolubility and cataract formation in the zebrafish cloche mutant lens

1 Vascular Biology Program/Department of Surgery, Children's Hospital and
Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.
2 Department of Molecular and Developmental Biology, Institute of Medical
Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639,
Japan.
3 Howard Hughes Medical Institute and Division of Hematology/Oncology,
Children's Hospital, Harvard Medical School, Boston, MA 02115,USA.
4 Vascular Biology Program/Department of Pathology, Children's Hospital and
Harvard Medical School, Boston, MA 02115, USA.
Author for correspondence (e-mail:
michael.klagsbrun{at}childrens.harvard.edu)
Accepted 3 May 2006
| SUMMARY |
|---|
|
|
|---|
-crystallin as a protein that was substantially
diminished in cloche mutants. Crystallins are the major structural
proteins in mouse, human and zebrafish lens. Defects in crystallins have
previously been shown in mice and humans to contribute to cataracts. The loss
of
-crystallin protein in cloche was not due to lowered mRNA
levels but rather to
-crystallin protein insolubility.
A-crystallin is a chaperone that protects proteins from misfolding and
becoming insoluble. The cloche lens is deficient in both
A-crystallin mRNA and protein during development from 2-5 dpf.
Overexpression of exogenous
A-crystallin rescued the
cloche lens phenotype, including solubilization of
-crystallin, increased lens transparency and induction of lens fiber
cell differentiation. Taken together, these results indicate that
A-crystallin expression is required for normal lens
development and demonstrate that cataract formation can be prevented in vivo.
In addition, these results show that proteomics is a valuable tool for
detecting protein alterations in zebrafish.
Key words: Cataract, Crystallin, Chaperone, Cloche, Eye, Lens, Zebrafish, cryaa
| INTRODUCTION |
|---|
|
|
|---|
-, ß- and
-crystallins. Each crystallin is expressed in the lens with spatial and
temporal expression patterns characteristic for each class. Mutations in human
C-crystallin (CRYGC) or
D-crystallin
(CRYGD) are associated with protein misfolding and protein
aggregation within the lens (Graw,
2004
-crystallins are structural
proteins,
A-crystallin is a member of the small heat shock protein
family and is also known as HSPB4 (Franck
et al., 2004
A-crystallin acts as a molecular chaperone
that protects proteins from misfolding
(Horwitz, 2003
Zebrafish embryos are excellent models for studying the genes that regulate
embryonic development (Talbot and Hopkins,
2000
; Thisse and Zon,
2002
). Zebrafish embryos are small, can be maintained on a large
scale and develop rapidly within days. Unlike mice, the embryos are
extracorporeal and transparent, allowing ready visualization of organs during
development. The transparency and relatively large eyes make zebrafish embryos
a particularly excellent model for studying eye development and ocular
diseases (Glass and Dahm,
2004
; Malicki,
2000
). Functional vision is developed by 3 days post-fertilization
(dpf) (Easter and Nicola,
1996
). Chemical mutagenesis screening has identified mutants with
an opaque lens, e.g. lop
(Vihtelic et al., 2005b
).
However, the cause of the opacity has not been established.
Forward genetics have been used to identify zebrafish genes involved in
normal development and genetic disorders, and to elucidate their function. For
example the cloche mutant lacks blood cells and blood vessels
(Qian et al., 2005
;
Stainier et al., 1995
;
Sumanas et al., 2005
;
Weber et al., 2005
). However,
a limitation of a strictly genetic approach is the inability to study protein
function. Proteomics is an alternative approach that identifies proteins,
measures their abundance, detects post-translational modifications, and
provides sequence data for cloning purposes. To date there have been very few
attempts to analyze zebrafish protein profiles by proteomics. We chose to
study protein defects in cloche as it is not clear what the genetic
defect is. Surprisingly, we noted that cloche not only had defects in
hematopoiesis and vasculogenesis, but also had lens opacity, a characteristic
of cataracts.
We report here that
-crystallin protein is insoluble in
cloche lens, resulting in lens opacity. Furthermore, the
cloche lens is deficient in
A-crystallin, a chaperone protein
that keeps proteins soluble. Overexpression of exogenous
A-crystallin (cryaa - Zebrafish Information Network)
rescues to a great degree the cloche lens phenotype; for example,
-crystallin protein becomes more soluble, the lens becomes more
transparent in vivo and lens fiber cell differentiation is induced. It was
concluded that
A-crystallin expression is required for normal lens
development and that these results are significant as they show, possibly for
the first time, that cataract formation can be prevented in vivo.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-crystallin guinea pig antiserum and anti-mouse
A-crystallin rabbit antiserum were kindly obtained from Dr M. Okamoto
(Nagoya, Japan) and from Dr J. J. Liang (Harvard Medical School, Boston, MA).
Horseradish peroxidase (HRP)-conjugated anti-guinea pig antibody was purchased
from Jackson ImmunoResearch Laboratories. HRP-conjugated anti-mouse antibody
was purchased from Amersham Biosciences UK.
Zebrafish maintenance
All animal protocols were approved by the Children's Hospital Institutional
Animal Care and Use Committee. Zebrafish were maintained as described
(Westerfield, 2000
), and
staged as described (Kimmel et al.,
1995
). Two independent cloche alleles,
clochem39 and cloches5, were used in
this study. Embryo age is defined as the number of days post-fertilization
(dpf). Euthanasia of zebrafish was accomplished by treatment with tricaine
(Sigma-Aldrich) before protein or RNA extraction. The homozygotes were
separated based on visual criteria such as cardiac edema, enlarged hearts and
lack of blood cell circulation.
Light and confocal microscopy
Living embryos in embryo media including tricaine were analyzed by
stereomicroscopy (Olympus). For confocal microscopic analysis, embryos were
embedded in 3% methyl cellulose in embryo media including tricaine. Stacks of
confocal micrographs were recorded from anesthetized zebrafish lens using a
Leica TCS SP2 (Leica Microsystems) confocal laser-scanning microscope fitted
to a DM IRE 2 inverted microscope with a 488 nm argon ion laser. Serial
sections were obtained at 1 µm intervals under the reflected light mode.
Images recorded under transmitted light were used as a general locator for the
quantitative analysis of selected reflected light images. Reflected light was
analyzed by the digital image analysis program (Leica Confocal Software and
ImageJ).
Protein extraction
Approximately 100 zebrafish embryos were transferred into 1.5 ml
microcentrifuge tubes. Centrifugation at 15,000 g for 5
minutes resulted in two phases. The lower phase contained the yolk, whereas
the upper phase contained zebrafish without yolk. The bottom of the tube was
pierced with a 26 G needle to remove the bottom yolk layer. To obtain total
embryo extracts containing soluble protein and cell membrane-associated
proteins, embryos were washed with ice-cold PBS three times and lysed in 8 M
urea, 4% CHAPS and 60 mM dithiothreitol by sonication for 20 seconds on ice,
and the lysates were left on ice for an additional 30 minutes. To avoid
protein degradation, proteinase inhibitor (Roche) and phosphatase inhibitor 1
and 2 (Sigma) were added to embryo lysates. Precipitates were removed by
centrifugation at 15,000 g for 20 minutes at 4°C. To
prepare soluble and insoluble protein, zebrafish embryos (2.5 dpf) were
homogenized in detergent-free 20 mM Tris-HCl (pH 7.5). Soluble and insoluble
fractions were separated by centrifugation.
Two dimensional gel electrophoresis
Total embryo extracts were analyzed by two-dimensional gel electrophoresis.
A BioRad protein IEF cell was used for the first dimension. Embryo extracts
(80 µg) were applied to immobilized pH gradient gel strips, 11 cm, linear
(pH 3-10). IEF was carried out at 20°C for 2 hours at 250 V (linear ramp),
and for 5.5 hours at 8000 V (linear ramp). The second dimension was a 10-20%
gradient SDS-PAGE for 1.5 hours at 150 V. Proteins were visualized by SYPRO
Ruby fluorescent staining (BioRad). The gels were photographed and the
intensities of gel spots were analyzed by a digital image analysis program
(ImageJ). The intensities of spots were normalized relative to wild-type
samples being 100%. Gel spots were excised using a spot cutter (The Proteome
Works, BioRad). Obtaining sufficient amounts of protein for sequencing (20
pmol) required excision from two or three spots. Samples were analyzed by
electrospray tandem mass spectrometry. These spectra were correlated with
known protein sequences using the Sequest algorithm and other programs
developed in the Harvard Microchemistry Lab
(Chittum et al., 1998
;
Eng et al., 1994
).
Western blots
Total embryo extracts, or extracts fractionated into soluble and insoluble
protein, were analyzed by western blot. Two µg of embryo extracts were
analyzed by 12% SDS-PAGE. The membranes were incubated with anti-mouse
A-crystallin antisera (1/2000 dilution) or anti-newt
-crystallin
antisera (1:2000 dilution) followed by HRP-conjugated anti-guinea pig IgG
(Jackson ImmunoResearch Laboratories, 1:5000) or anti-rabbit IgG (Amersham
Pharmacia Biotech; 1: 10,000), and visualization with enhanced
chemiluminescence (Perkin Elmer Life Science). The specificity of each
antibody was confirmed by western blotting of lysates prepared by transiently
transfecting Chinese Hamster Ovarian cells (American Type Culture Collection)
with expression constructs of zebrafish
A-(Runkle et al.,
2002
) (GenBank Accession Number, NM 152950),
B1-(Posner et al.,
1999
; Smith et al.,
2006
) (GenBank Accession Number, NM 131157),
ßB1-(Chen et al.,
2001
) (GenBank Accession Number, NM 173231) and
-crystallin genes. Cell maintenance and gene transfection
procedures were as described previously
(Goishi et al., 2003
). Protein
bands were analyzed by the digital image analysis program (ImageJ). Results
were normalized by setting the densitometer of the wild-type samples as
100%.
Cloning of crystallin (Cry) genes
Sixteen peptide sequences from tandem mass spectrometry were analyzed in a
BLAST search. Twelve of the peptide sequences were completely identical to
several EST clones. Oligonucleotide primers for PCR were generated based on
matched EST clone sequences. Using the SMARTRACE cDNA Amplification Kit (BD
bioscience), 5' and 3' zebrafish
-crystallin cDNA
ends were obtained by RT-PCR from 48 hpf embryo total RNA.
Sense primers for 3'RACE are follows: CryG-S1, 5'-GGCGACTGTGGTGACTTCTCCTCCTACA-3'; CryG-S2, 5'-CATGAAGGTCACCTTCTTTGAGGA-3'; CryG-S3, 5'-GCAAACCATGATGGGCAAAGGTC-3'; CryG-S4, 5'-AGTAACCATGATGGGCAAGGTCAT-3'; CryG-S5, 5'-CGCAACCATGATGGGCAAGGTCGTT-3', CryG-S6, 5'-CGCAAACATGATGGGCAAGGTCGCC-3'; CryG-orf1-s, 5'-AACATGAAGGTCACCTTCTTTGAGGACA-3'.
Antisense primers for 5'RACE are follows: CryG-As1, 5'-CCGAAGTGCCACATCCTGCCTCTGTAGT-3'; CryG-As2, 5'-GTACCAAGAGTCCATGATACGCCTCA-3'; CryG-orf1-AS, 5'-CTAGTACCAAGAGTCCATGATACGCCTCA-3'.
PCR products for
-crystallin genes were subcloned into the
pCRII/TOPO vector (Invitrogen).
-crystallin open reading
frames were generated by RT-PCR. PCR products were subcloned into the
pCRII/TOPO vector and the expression vector pcDNA3.1/V5-His/TOPO (Invitrogen).
An EST database BLAST search with mammalian
B-crystallin protein
sequences revealed a second zebrafish
B-crystallin gene that
was cloned by PCR. The second
B-crystallin gene was amplified
using the following primers: CRY-ABb-S,
5'-TTGCAGAAGAGGCCCAGACTCA-3'; CRY-ABb-As-stop,
5'-CACAAACATTTGGCCGTCAGTAGG-3'.
Whole-mount in situ hybridization and histology
Whole-mount in situ hybridization was performed as previously described
(Bovenkamp et al., 2004
;
Lee et al., 2002
). Briefly,
crystallin cDNAs were used as a template to synthesize digoxigenin-labeled
sense and antisense riboprobes. Embryos were fixed in 4% paraformaldehyde
overnight and then permeabilized by proteinase K treatment prior to
hybridization. After color was detected with alkaline phosphatase substrates,
the embryos were mounted in glycerol and photographed. Paraformaldehyde fixed,
paraffin-embedded embryos were used for histology (Hematoxylin and Eosin).
RT-PCR
Two µg of total RNA from 2 dpf, 3 dpf and 4 dpf zebrafish were isolated
and reverse transcribed by using SuperScript II reverse transcriptase
(Invitrogen) according to the manufacturer's suggestions. Zebrafish
elongation factor 1
(ef1a; GenBank Accession Number,
NM 131263) was used as a loading control.
Each sample was amplified with the following primers.
A-crystallin: CRYAA-S,
5'-TATGGATATTGCGATCCAACACCCTT-3'; CRYAA-AS,
5'-AGAGCCTGAGTTGCTCTTGTCCTCG-3'.
B1-crystallin:
CRYAB-S, 5'-TGTCAGCTCCAAACTAAGGTACAATG-3'; CRYAB-AS,
5'-TGCAGCTCTGGACAGGTTCAT-3'. ßB1-crystallin:
CRY-BB1-S, 5'-CACCATGTCTCAGACCGCCAAA-3'; CRY-BB1-As,
5'-CTGTTTAGCGGCGGTCATGTTGA-3'.
Bb-crystallin
(GenBank Accession Number AY939876): CRY-ABb-S; CRY-ABb-As,
5'-CTTCTGAGGGCCAGCGACGGT-3'.
-crystallin: Cry-G-S1
and Cry-G-As1. flk1 (GenBank Accession Number, NM 131472):
Flk1-1098S, 5'-TGCCATCGAACCAGAAAGACCAAGAG-3'; Flk1-1299As,
5'-TGCCCTTGTCCTCCATTGTCACATTA-3'. ef1a: Ef1-S,
5'-GCCCCTGCCAATGTA-3'; Ef1-As,
5'-GGGCTTGCCAGGG-AC-3'.
Microinjection
Zebrafish
A- and
-crystallin cDNA were
subcloned into pXT7, which was obtained from Dr S. Sokol (Beth Israel,
Boston). To generate capped mRNA, plasmids were linearized by SalI
and transcribed with T7 RNA polymerase using the mMESSAGE mMACHINE (Ambion)
according to the manufacturer's instructions. For microinjection of RNA into
zebrafish, 100 pg of synthesized mRNA were injected into the one-to four-cell
stage embryos obtained from crosses between cloche heterozygotes. The
A-crystallin promoter-EGFP
(Kurita et al., 2003
) was
injected (100 pg) into one-to four-cell stage embryos. The injected embryos
were examined under a fluorescence microscope (Olympus).
Statistical analysis
The Mann-Whitney U test was used to test for differences between
two groups. Accepted level of significance for all tests was
P<0.05. Box-and- whisker plots were generated to show the levels
of reflectance intensity. The line in the box corresponds to the median value.
The lower and upper whiskers correspond to 10th and 90th percentiles,
respectively.
Photoreceptor staining
Embryos were fixed in 4% paraformaldehyde/PBS (pH 7.4) for 2 hours at room
temperature, incubated in 30% sucrose/PBS overnight, and embedded in Neg50
frozen section medium (Richard-Allen Scientific). Sections of 10 µm section
were prepared, rehydrated and blocked in 0.1% Tween20, 10% goat serum and 0.5%
TritonX-100 in PBS. Immunohistochemistry was carried out with an antibody
zpr-1 that detects zebrafish photoreceptors, a gift from Dr J. Malicki
(Massachusetts Eye and Ear Infirmary, Boston)
(Pujic and Malicki, 2001
).
Analysis was carried out by confocal microscopy.
|
| RESULTS |
|---|
|
|
|---|
-crystallin
(Fig. 1B). Eight different
-crystallin cDNAs were isolated from 2 dpf embryos and the encoded
proteins were 95-100% identical at the amino acid level (GenBank Accession
Numbers: DQ294939, DQ294940, DQ288267, DQ294941, DQ294942, DQ294943, DQ298448,
DQ298449). One of these cDNAs was designated as embryonic zebrafish
-crystallin M2 type1 (
EM2-1-crystallin,
GenBank Accession Number, DQ294939) (Fig.
1B, top, EM2-1). This zebrafish cDNA encodes a protein of 174
putative amino acids with two ß/
-crystallin domains, the same as
in other species. It is 78% homologous in amino acid sequence to a very
recently described zebrafish
-crystallin M2 gene
(crygm2b; GenBank Accession Number, NM001020783) that had been cloned
from adult lens tissue (Vihtelic et al.,
2005a
B-crystallin gene, which we called
Bb-crystallin (cryabb; GenBank Accession Number,
AY939876). This gene is identical to
B2-cystallin (GenBank
Accession Number; DQ113417) (Smith et al.,
2006
B1-crystallin (GenBank Accession Number, NM 131157)
(Posner et al., 1999
Crystallins are expressed mostly in lens and constitute 80-90% of lens
protein (Bloemendal et al.,
2004
; Graw and Loster,
2003
). The spatiotemporal expression pattern of
-crystallin was analyzed by whole-mount in situ hybridization
using our cloned zebrafish
-crystallin EM2-1 cDNA. At 2 dpf,
-crystallin was expressed entirely in the lens
(Fig. 1C). However, unlike the
protein, there was no significant difference between cloche and
wild-type embryo
-crystallin gene expression.
A-crystallin gene expression is down-regulated in cloche
There are several classes of crystallins, including
-,
ß- and
-crystallin, and each class has several
different genes (Chen et al.,
2001
; Posner et al.,
1999
; Runkle et al.,
2002
; Vihtelic et al.,
2005a
; Wistow et al.,
2005
; Smith et al.,
2006
). The expression levels of
A-,
Bb-, ßB1- and
-crystallin were
analyzed by semi-quantitative RT-PCR (Fig.
2A). This analysis showed that
A-crystallin gene
expression was strongly downregulated in cloche, whereas gene
expression of the other crystallins was not altered. The cloche
mutant is defective in hematopoiesis and blood vessel development
(Qian et al., 2005
;
Stainier et al., 1995
;
Sumanas et al., 2005
;
Weber et al., 2005
). As a
control to confirm the cloche phenotype, the RNA levels of
flk1, a VEGF receptor expressed by endothelial cells, were diminished
in cloche. As a loading control, the levels of ef1a, which
are known to remain constant from 8 hours to 72 hours of zebrafish development
(Qian et al., 2005
;
Xu et al., 2003
), did not
change.
|
A-crystallin mRNA levels decrease in vivo as
well, an
A-crystallin promoter-EGFP construct was injected
into cloche embryos (n=470; homozygous=120, wild-type
siblings=350) (Fig. 2B).
The specificity and reliability of this had been described previously
(Kurita et al., 2003
Western blotting of total extract with specific anti-mouse
A-crystallin antibody showed an 85% reduction in the levels of
A-crystallin protein (Fig.
2C) consistent with the RNA results. A time course revealed that
the level of
A-crystallin mRNA in cloche were
diminished and these low mRNA levels remained constant from 2-5 dpf
(Fig. 2D). However, the levels
of
-crystallin were the same developmentally in both wild type
and cloche (Fig.
2D).
The cloche embryo lens has cataracts
Crystallin defects are associated with cataracts, which are characterized
by light scattering opacity of the lens
(Bloemendal et al., 2004
;
Graw, 2004
). Zebrafish embryos
are transparent and thus the gross morphology of the eye and lens can be
examined readily by bright-field microscopy of living zebrafish embryos. At
2.5 dpf, lenses of wild-type embryo siblings are completely transparent (0
opaque/300 embryos, 0% opacity) (Fig.
3A, top), whereas the cloche embryo lenses are cloudy
with light scattering in 428 of 633 embryos (68% opacity)
(Fig. 3A, bottom). By 3 dpf,
the cloudy lens phenotype was more apparent, ranging from 84% (533/633)
opacity in one analysis to 100% opacity (34/34) in another. In another
approach, lenses were analyzed by stereomicroscopy with highly oblique
(80° off-axis) illumination. There was no light scattering in wild-type
lens, whereas strong reflectance was observed in the cloche lens (not
shown).
During normal lens development, the nuclei of lens fiber cells that express crystallins are readily detected by histology at 2 dpf, diminished by 3 dpf and absent by 4 dpf, at which point the lens fiber cells had become terminally differentiated and the lens was transparent (Fig. 3B, top panels). By contrast, in the cloche embryo, lens fiber cell nuclei were still detectable at 4 dpf (Fig. 3B, bottom panels) and even at 5 dpf (not shown). The presence of nuclei in the cloche lens was confirmed by staining with Hoechst 33342 which visualizes nuclei (not shown). A quantitative analysis shows an 85-90% loss of wild-type nuclei by 3 dpf but persistent appearance of nuclei in cloche at 2-4 dpf (Fig. 3C, n=14). The persistence of nuclei in the cloche mutant suggests that this phenotype was not due to delayed development.
Lenses were also analyzed by confocal microscopy to measure lens
transparency in a non-invasive and more quantitative manner. At 2-4 dpf,
wild-type sibling lens were totally transparent
(Fig. 3D, top panels), whereas
the cloche lenses displayed intensive light scattering in the lens
core (Fig. 3D, bottom panels).
The intensity of reflectance in the live cloche embryo lens increased
with time. The median value of intensity was 37-fold higher in cloche
lens compared with the wild-type lens at 4 dpf (P=0.0209)
(Fig. 3E). Another allele of a
zebrafish cloche mutant, cloches5
(Brown et al., 2000
;
Qian et al., 2005
;
Weber et al., 2005
), was also
analyzed for the presence of cataracts. As in clochem39,
the lens was opaque (not shown). However, confocal microscope analysis showed
a quantitative high degree of reflectance in cloches5
comparable with
clochem39(Fig.
3F,G).
|
Besides the lenses other parts of the zebrafish eye were examined, in
particular the retina, by Dr L. Smith (Children's Hospital, Boston, MA, USA)
and Dr J. Malicki (Massachusetts Eye and Ear Infirmary, Boston, MA, USA) who
specialize in retinal disease (Smith,
2003
; Malicki,
2000
). Immunohistochemistry with a monoclonal antibody zpr-1 that
detects photoreceptors (Larison and
Bremiller, 1990
; Pujic and
Malicki, 2001
) demonstrated that the photoreceptors (green)
develop normally in cloche even at 5 dpf. The thickness of the
retinal layers at 3.5 dpf and 5 dpf were similar to wild-type retina (see Fig.
S1 in the supplementary material).
Formation of cloche lens cataracts is prevented by overexpressing
A-crystallin
A-crystallin is a small heat shock protein that acts as a chaperone,
inhibits aggregation of several target proteins and maintains the solubility
of crystallin proteins in vitro (Dahlman
et al., 2005
; Horwitz,
2003
). Accordingly, zebrafish
A-crystallin mRNA
was injected into zebrafish embryos at the one- to four-cell stage and the
effects on opacity were analyzed by bright-field microscopy, confocal
microscopy and histology (Fig.
4). Wild-type embryo lenses were clear (0% opaque, n=300)
(Fig. 4A, lane 1). Uninjected
cloche embryos had a cloudy and opaque lens (84% opaque,
n=633), as measured by bright-field microscopy
(Fig. 4A, panel 2). However,
cloche embryos injected with
A-crystallin mRNA showed
a much lower frequency of opacity (19.8% opaque, n=96) at 4 dpf
(Fig. 4A, panel 3). Conversely,
overexpression of
-crystallin, which has no chaperone
activity, in cloche embryos had no protective effect on lens opacity
(100% opaque, n=35) (Fig.
4A, panel 4).
The efficacy of rescue was also measured by confocal microscopy
(Fig. 4B). There was no
reflectance in wild-type embryos (Fig.
4B, panel 1) and a great degree of reflectance in cloche
lens (Fig. 4B, panel 2).
However, overexpression of
A-crystallin resulted in a
significant decrease in reflectance. The median lens reflectance
(n=4) of cloche lens was 70 units but when
A-crystallin was overexpressed the median reflectance
decreased to 41 units (n=4, P=0.0433,
Fig. 4B, panel 3). However, as
a control for possible non-specific effects resulting from mRNA injections,
overexpression of
-crystallin had no protective effect
(Fig. 4B, panel 4). The median
reflectance value was 85 units, more than cloche but not
statistically significant (n=4). The differences between
overexpression of
A-crystallin compared with
overexpression of
-crystallin were substantial and significant
(P=0.0209).
|
A-crystallin (4
dpf) also rescued the lens fiber nuclei phenotype
(Fig. 4C). Unlike
cloche at 4 dpf (Fig.
4C, panel 2) nuclei were not detected when
A-
crystallin was overexpressed (Fig.
4C, panel 3) and the lens appeared more like the wild-type lens at
4 dpf. (Fig. 4C, panel 1).
However, overexpression of
-crystallin in cloche
embryos had no protective effect on lens nuclei
(Fig. 4C, panel 4).
A-crystallin overexpression maintains cloche
-crystallin solubility
The increased transparency as a result of overexpression of
A-crystallin could be due to its preventing
-crystallin
from becoming insoluble. Accordingly, the solubility of
-crystallin
protein was analyzed in cloche with and without
A-crystallin overexpression
(Fig. 5). Protein was extracted
from 2.5 dpf zebrafish embryos in detergent-free 20 mM Tris-HCl (pH 7.5),
centrifuged to separate soluble and insoluble fractions, and analyzed by
western blot. Of the total protein, 83% of wild-type embryo
-crystallin
was soluble and 17% was insoluble, whereas 20% of cloche
-crystallin was soluble and 80% was insoluble
(Fig. 5A). However, when
A-crystallin was overexpressed in cloche, there was a
significant increase in soluble
-crystallin levels, with over 60% of
the protein being soluble (Fig.
5B). These results show that
A-crystallin rescues the
insolubility phenotype and indicates that the lower levels of cloche
-crystallin shown by 2D gel electrophoresis
(Fig. 1A) were due to protein
insolubility.
Similar results were found in the cloches5 allele (see
Fig. S2 in the supplementary material).
A-crystallin was not expressed
at the protein and mRNA levels,
-crystallin was insoluble, and the
cataract phenotype was rescued by overexpression of
A-crystallin mRNA.
| DISCUSSION |
|---|
|
|
|---|
A-crystallin, a chaperone for
-crystallin, is
not expressed, the result being insolubility of
-crystallin, and lack
of terminally differentiated mature lens fiber cells. The net results of these
defects are lens opacity and loss of transparency.
The evidence for this mechanism combines protein and zebrafish analysis.
cloche
-crystallin is expressed at the same mRNA
levels as wild-type
-crystallin and is localized to the lens
in a normal manner as shown by in situ hybridization. However, the
cloche
-crystallin protein is mostly insoluble as shown by
2D-gel electrophoresis and western blot. Thus, there appears to be a
-crystallin protein defect in cloche. However,
A-crystallin mRNA expression, promoter reporter activity in
the lens and protein levels are all greatly diminished.
A-crystallin is
not only a structural lens protein but is also a functional chaperone that
prevents protein denaturation in vitro
(Dahlman et al., 2005
;
Horwitz, 2003
). Evidence that
A-crystallin acts as a chaperone is that the overexpression of
A-crystallin in cloche mutants prevented cataract
formation in 80.2% of the embryos as measured by bright-field microscopy.
Quantitative analysis in the living embryo lens by confocal microscopy showed
that reflectance was reduced by 41%. Biochemical analysis revealed that the
insolubility of
-crystallin was reduced by 60%. In addition,
overexpression of
A-crystallin induced lens fiber cell
denucleation as shown by histological staining, contributing to an increase in
lens transparency. As a control for crystallin specificities,
-crystallin overexpression had no such protective effects.
These results in vivo are consistent with previous reports that zebrafish
A-crystallin functions as a chaperone for target substrates in vitro
(Dahlman et al., 2005
).
Our results are consistent with a number of reports in mammals that
crystallin defects are associated with cataracts. For example, in mice,
targeted deletion of
A-crystallin leads to cataracts
(Brady et al., 1997
). Missense
mutations in
A-crystallin have been found in mice with
cataracts (Chang et al., 1999
;
Graw et al., 2001
). Mouse
A/
B crystallin double knockouts show that both
-crystallin genes are necessary for proper fiber cell formation
(Boyle et al., 2003
). At least
20 missense, nonsense, deletion and insertion mutations in mouse
-crystallin have been identified
(Graw, 2004
). In humans,
missense mutations in
A-crystallin have been found in human
autosomal dominant congenital cataracts
(Litt et al., 1998
). A
nonsense mutation in
A-crystallin is associated with autosomal
recessive congenital cataracts (Pras et
al., 2000
). There are also human
-crystallin
defects associated with cataracts (Graw,
2004
). Missense, nonsense and insertion mutations associated with
cataracts have been found in
C-crystallin and
D-crystallin (Graw,
2004
). These studies have provided good evidence linking
crystallin defects to mammalian cataracts. However, a mechanism for cataract
formation and prevention of cataracts in the mammalian lens in vivo has been
lacking so far.
|
A-crystallin expression is very
diminished compared with wild type and these low mRNA and promoter levels
remain constant from 2-5 dpf. The relatively high levels of
-crystallin do not change in this time period. These results
suggest that
-crystallin will be irreversibly insoluble
throughout development. Furthermore, during normal lens development, the
nuclei of lens fiber cells that express crystallins were readily detected by
histology at 2 dpf, greatly diminished by 3 dpf and absent by 4 dpf, at which
point the lens fiber cells had become terminally differentiated and the lens
was transparent. However, in the cloche embryo, lens fiber cell
nuclei were still detectable at 5 dpf. The persistent presence of nuclei and
concomitant lack of transparency in the developing cloche mutant is
inconsistent with delayed development. In addition, we find the same lens
cataract phenotype and rescue by
A-crystallin mRNA in two
different alleles of zebrafish cloche, clochem39 and
cloches5 (see Fig. S2 in the supplementary material), that
have different genetic alterations, making it unlikely that cataract formation
in cloche is non-specific. A degree of specificity for the lens
phenotype is indicated in that the photoreceptors in cloche retina
appear structurally normal in development at 3.5-5 dpf (see Fig. S1 in the
supplementary material). Finally, we examined a zebrafish mutant,
crash&burn, that is developmentally delayed because of loss of
bmyb function, resulting in decreased cyclin B1 expression and
mitotic arrest (Shepard et al.,
2005
Zebrafish cloche was originally described as a mutant that had
defects in hematopoiesis and blood vessel development
(Stainier et al., 1995
).
Whether there is a link between the cataract phenotype and this blood/blood
vessel phenotype is not clear, the lens being avascular. VEGF is a major
regulator of angiogenesis. VEGF acting through VEGF receptor tyrosine kinases
is necessary for axial vessel and intersegmental vessel development
(Goishi and Klagsbrun, 2004
).
These interactions can be disrupted by administration of VEGFR2 kinase
inhibitors or morpholino antisense oligos (MO) to zebrafish embryos
(Chan et al., 2002
;
Lee et al., 2002
;
Nasevicius et al., 2000
).
However, neither a VEGF receptor kinase inhibitor nor an anti-VEGF MO induced
a cataract phenotype in wild-type zebrafish embryos, even at 5 dpf. Another
plausible candidate could be FGF2, one of the first angiogenesis factors to be
identified (Shing et al.,
1984
). Endothelial cells in culture respond to FGF2 by migrating
and proliferating mainly via FGF receptor 1 (FGFR1). In addition to a role in
angiogenesis, FGFR1 is expressed by hematopoietic/endothelial precursor cells
(Magnusson et al., 2005
) and
FGF signaling regulates hematopoietic development
(Faloon et al., 2000
). FGF
also initiates lens fiber cell differentiation in mice
(Lovicu and McAvoy, 2005
).
Whether FGF defects are linked to both loss of blood/blood vessels and
cataracts remains unclear. Our preliminary data showed that FGFR kinase
inhibitor did not induce a cataract phenotype in wild-type zebrafish lens.
There are several cloche alleles, one being
clochem39, which is a spontaneous mutant, and another
being cloches5, which is chemically induced mutant
(Brown et al., 2000
;
Qian et al., 2005
;
Weber et al., 2005
). The
original studies carried out here have used clochem39
embryos. However, cloches5 also shows diminished
A-crystallin levels, insoluble
-crystallin protein, and
evidence of cataracts. In both alleles, overexpression of
A-crystallin in cloche rescued the cataract
phenotype.
Our results are significant as they may constitute the first demonstration
of blocking cataract formation in vivo. There may be some practical
consequences of using zebrafish as a cataract model. Zebrafish are amenable to
large-scale, systematic screens to identify small molecules that can suppress
disease phenotypes (Peterson and Fishman,
2004
; Zon and Peterson,
2005
). For example, the zebrafish mutation gridlock
disrupts aortic blood flow in a region and manner akin to aortic coarctation
in the human. A zebrafish small molecule screen has been used to discover a
class of compounds that suppressed the coarctation phenotype
(Peterson et al., 2004
). The
zebrafish lens is very visible, transparent and relatively large. It is
possible to administer drugs to zebrafish in their swim medium
(Peterson and Fishman, 2004
;
Zon and Peterson, 2005
); thus,
zebrafish cloche may be useful for screening anti-cataract drugs.
Finally, our results demonstrate the value of proteomics in detecting
protein alterations in zebrafish mutants. Most studies in zebrafish are based
on genetic analysis. However, gene expression and mRNA abundance do not
necessarily correlate with protein abundance. Another major limitation of
mRNA-based approaches is the inability to detect post-translational
modifications that may determine protein function. In our study,
-crystallin mRNA was normal but the protein was not soluble.
We propose that zebrafish proteomics will provide a new dimension in zebrafish
research.
Supplementary material
Supplementary material for this article is available at
http://dev.biologists.org/cgi/content/full/133/13/2585/DC1
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
| REFERENCES |
|---|
|
|
|---|
Bloemendal, H., de Jong, W., Jaenicke, R., Lubsen, N. H., Slingsby, C. and Tardieu, A. (2004). Ageing and vision: structure, stability and function of lens crystallins. Prog. Biophys. Mol. Biol. 86,407 -485.[CrossRef][Medline]
Bovenkamp, D. E., Goishi, K., Bahary, N., Davidson, A. J., Zhou, Y., Becker, T., Becker, C. G., Zon, L. I. and Klagsbrun, M. (2004). Expression and mapping of duplicate neuropilin-1 and neuropilin-2 genes in developing zebrafish. Gene Expr. Patterns 4,361 -370.[CrossRef][Medline]
Boyle, D. L., Takemoto, L., Brady, J. P. and Wawrousek, E. F. (2003). Morphological characterization of the Alpha A- and Alpha B-crystallin double knockout mouse lens. BMC Ophthalmol. 3,3 .[CrossRef][Medline]
Brady, J. P., Garland, D., Duglas-Tabor, Y., Robison, W. G., Jr,
Groome, A. and Wawrousek, E. F. (1997). Targeted disruption
of the mouse alpha A-crystallin gene induces cataract and cytoplasmic
inclusion bodies containing the small heat shock protein alpha B-crystallin.
Proc. Natl. Acad. Sci. USA
94,884
-889.
Brown, L. A., Rodaway, A. R., Schilling, T. F., Jowett, T., Ingham, P. W., Patient, R. K. and Sharrocks, A. D. (2000). Insights into early vasculogenesis revealed by expression of the ETS-domain transcription factor Fli-1 in wild-type and mutant zebrafish embryos. Mech. Dev. 90,237 -252.[CrossRef][Medline]
Chan, J., Bayliss, P. E., Wood, J. M. and Roberts, T. M. (2002). Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 1, 257-267.[CrossRef][Medline]
Chang, B., Hawes, N. L., Roderick, T. H., Smith, R. S., Heckenlively, J. R., Horwitz, J. and Davisson, M. T. (1999). Identification of a missense mutation in the alphaA-crystallin gene of the lop18 mouse. Mol. Vis. 5, 21.[Medline]
Chen, J. Y., Chang, B. E., Chen, Y. H., Lin, C. J., Wu, J. L. and Kuo, C. M. (2001). Molecular cloning, developmental expression, and hormonal regulation of zebrafish (Danio rerio) beta crystallin B1, a member of the superfamily of beta crystallin proteins. Biochem. Biophys. Res. Commun. 285,105 -110.[CrossRef][Medline]
Chittum, H. S., Lane, W. S., Carlson, B. A., Roller, P. P., Lung, F. D., Lee, B. J. and Hatfield, D. L. (1998). Rabbit beta-globin is extended beyond its UGA stop codon by multiple suppressions and translational reading gaps. Biochemistry 37,10866 -10870.[CrossRef][Medline]
Dahlman, J. M., Margot, K. L., Ding, L., Horwitz, J. and Posner, M. (2005). Zebrafish alpha-crystallins: protein structure and chaperone-like activity compared to their mammalian orthologs. Mol. Vis. 11,88 -96.[Medline]
Easter, S. S., Jr and Nicola, G. N. (1996). The development of vision in the zebrafish (Danio rerio). Dev. Biol. 180,646 -663.[CrossRef][Medline]
Eng, J. K., McCormack, A. L. and Yates, J. R. R. (1994). An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5,976 -989.[CrossRef]
Faloon, P., Arentson, E., Kazarov, A., Deng, C. X., Porcher, C., Orkin, S. and Choi, K. (2000). Basic fibroblast growth factor positively regulates hematopoietic development. Development 127,1931 -1941.[Abstract]
Foster, A. and Resnikoff, S. (2005). The impact of Vision 2020 on global blindness. Eye 19,1133 -1135.[CrossRef][Medline]
Franck, E., Madsen, O., van Rheede, T., Ricard, G., Huynen, M. A. and de Jong, W. W. (2004). Evolutionary diversity of vertebrate small heat shock proteins. J. Mol. Evol. 59,792 -805.[CrossRef][Medline]
Glass, A. S. and Dahm, R. (2004). The zebrafish as a model organism for eye development. Ophthalmic Res. 36,4 -24.[CrossRef][Medline]
Goishi, K. and Klagsbrun, M. (2004). Vascular endothelial growth factor and its receptors in embryonic zebrafish blood vessel development. Curr. Top. Dev. Biol. 62,127 -152.[Medline]
Goishi, K., Lee, P., Davidson, A. J., Nishi, E., Zon, L. I. and Klagsbrun, M. (2003). Inhibition of zebrafish epidermal growth factor receptor activity results in cardiovascular defects. Mech. Dev. 120,811 -822.[CrossRef][Medline]
Graw, J. (2004). Congenital hereditary cataracts. Int. J. Dev. Biol. 48,1031 -1044.[CrossRef][Medline]
Graw, J. and Loster, J. (2003). Developmental genetics in ophthalmology. Ophthalmic Genet. 24, 1-33.[CrossRef][Medline]
Graw, J., Loster, J., Soewarto, D., Fuchs, H., Meyer, B., Reis,
A., Wolf, E., Balling, R. and Hrabe de Angelis, M. (2001).
Characterization of a new, dominant V124E mutation in the mouse
alphaA-crystallin-encoding gene. Invest. Ophthalmol. Vis.
Sci. 42,2909
-2915.
Horwitz, J. (2003). Alpha-crystallin. Exp. Eye Res. 76,145 -153.[CrossRef][Medline]
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. and Schilling, T. F. (1995). Stages of embryonic development of the zebrafish. Dev. Dyn. 203,253 -310.[Medline]
Kurita, R., Sagara, H., Aoki, Y., Link, B. A., Arai, K. and Watanabe, S. (2003). Suppression of lens growth by alphaA-crystallin promoter-driven expression of diphtheria toxin results in disruption of retinal cell organization in zebrafish. Dev. Biol. 255,113 -127.[CrossRef][Medline]
Larison, K. D. and Bremiller, R. (1990). Early onset of phenotype and cell patterning in the embryonic zebrafish retina. Development 109,567 -576.[Abstract]
Lee, P., Goishi, K., Davidson, A. J., Mannix, R., Zon, L. and
Klagsbrun, M. (2002). Neuropilin-1 is required for vascular
development and is a mediator of VEGF-dependent angiogenesis in zebrafish.
Proc. Natl. Acad. Sci. USA
99,10470
-10475.
Litt, M., Kramer, P., LaMorticella, D. M., Murphey, W., Lovrien,
E. W. and Weleber, R. G. (1998). Autosomal dominant
congenital cataract associated with a missense mutation in the human alpha
crystallin gene CRYAA. Hum. Mol. Genet.
7, 471-474.
Lovicu, F. J. and McAvoy, J. W. (2005). Growth factor regulation of lens development. Dev. Biol. 280, 1-14.[CrossRef][Medline]
Magnusson, P. U., Ronca, R., Dell'Era, P., Carlstedt, P.,
Jakobsson, L., Partanen, J., Dimberg, A. and Claesson-Welsh, L.
(2005). Fibroblast growth factor receptor-1 expression is
required for hematopoietic but not endothelial cell development.
Arterioscler. Thromb. Vasc. Biol.
25,944
-949.
Malicki, J. (2000). Genetic analysis of eye development in zebrafish. Results Probl. Cell Differ. 31,257 -282.[Medline]
Nasevicius, A., Larson, J. and Ekker, S. C. (2000). Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast 17,294 -301.[CrossRef][Medline]
Peterson, R. T. and Fishman, M. C. (2004). Discovery and use of small molecules for probing biological processes in zebrafish. Methods Cell Biol. 76,569 -591.[Medline]
Peterson, R. T., Shaw, S. Y., Peterson, T. A., Milan, D. J., Zhong, T. P., Schreiber, S. L., MacRae, C. A. and Fishman, M. C. (2004). Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotechnol. 22,595 -599.[CrossRef][Medline]
Posner, M., Kantorow, M. and Horwitz, J. (1999). Cloning, sequencing and differential expression of alphaB-crystallin in the zebrafish, Danio rerio. Biochim. Biophys. Acta 1447,271 -277.[Medline]
Pras, E., Frydman, M., Levy-Nissenbaum, E., Bakhan, T., Raz, J.,
Assia, E. I. and Goldman, B. (2000). A nonsense mutation
(W9X) in CRYAA causes autosomal recessive cataract in an inbred Jewish Persian
family. Invest. Ophthalmol. Vis. Sci.
41,3511
-3515.
Pujic, Z. and Malicki, J. (2001). Mutation of the zebrafish glass onion locus causes early cell-nonautonomous loss of neuroepithelial integrity followed by severe neuronal patterning defects in the retina. Dev. Biol. 234,454 -469.[CrossRef][Medline]
Qian, F., Zhen, F., Ong, C., Jin, S. W., Meng Soo, H., Stainier, D. Y., Lin, S., Peng, J. and Wen, Z. (2005). Microarray analysis of zebrafish cloche mutant using amplified cDNA and identification of potential downstream target genes. Dev. Dyn. 233,1163 -1172.[CrossRef][Medline]
Resnikoff, S., Pascolini, D., Etya'ale, D., Kocur, I., Pararajasegaram, R., Pokharel, G. P. and Mariotti, S. P. (2004). Global data on visual impairment in the year 2002. Bull. World Health Organ. 82,844 -851.[Medline]
Runkle, S., Hill, J., Kantorow, M., Horwitz, J. and Posner, M. (2002). Sequence and spatial expression of zebrafish (Danio rerio) alphaA-crystallin. Mol. Vis. 8, 45-50.[Medline]
Shepard, J. L., Amatruda, J. F., Stern, H. M., Subramanian, A.,
Finkelstein, D., Ziai, J., Finley, K. R., Pfaff, K. L., Hersey, C., Zhou, Y.
et al. (2005). A zebrafish bmyb mutation causes genome
instability and increased cancer susceptibility. Proc. Natl. Acad.
Sci. USA 102,13194
-13199.
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray,
J. and Klagsbrun, M. (1984). Heparin affinity: purification
of a tumor-derived capillary endothelial cell growth factor.
Science 223,1296
-1299.
Smith, A. A., Wyatt, K., Vacha, J., Vihtelic, T. S., Zigler, J. S., Jr, Wistow, G. J. and Posner, M. (2006). Gene duplication and separation of functions in alphaB-crystallin from zebrafish (Danio rerio). FEBS J. 273,481 -490.[CrossRef][Medline]
Smith, L. E. (2003). Pathogenesis of retinopathy of prematurity. Semin. Neonatol. 8, 469-473.[CrossRef][Medline]
Stainier, D. Y., Weinstein, B. M., Detrich, H. W., 3rd, Zon, L. I. and Fishman, M. C. (1995). Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development 121,3141 -3150.[Abstract]
Stern, H. M., Murphey, R. D., Shepard, J. L., Amatruda, J. F., Straub, C. T., Pfaff, K. L., Weber, G., Tallarico, J. A., King, R. W. and Zon, L. I. (2005). Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat. Chem. Biol. 1, 366-370.[CrossRef][Medline]
Sumanas, S., Jorniak, T. and Lin, S. (2005).
Identification of novel vascular endothelial-specific genes by the microarray
analysis of the zebrafish cloche mutants. Blood
106,534
-541.
Talbot, W. S. and Hopkins, N. (2000). Zebrafish
mutations and functional analysis of the vertebrate genome. Genes
Dev. 14,755
-762.
Thisse, C. and Zon, L. I. (2002). Organogenesis
- heart and blood formation from the zebrafish point of view.
Science 295,457
-462.